Comments
Dr Reddy’s Laboratories Ltd has launched of Methylphenidate Hydrochloride Extended-Release Tablets, a therapeutic equivalent generic version of Concerta (methylphenidate Hydrochloride) Extended-Release Tablets in the US market.
The Concerta brand and generic market had US sales of approximately $1.159 billion for the most recent twelve months ending in June 2020 according to IQVIA Health.
Dr Reddy’s Methylphenidate Hydrochloride Extended-Release Tablets are available in strengths of 18 mg, 27 mg, 36 mg, and 54 mg tablets in bottle count sizes of 100, according to a release.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.